Table 1.
Donor characteristics.
| Sevoflurane group | Control group | Mann-Whitney, P value | |
|---|---|---|---|
| Donor age, y | 32 (24–46) | 39 (25–46) | 0,515 |
| Weight, kg | 75 (63,5–80) | 75,5 (70–85) | 0,596 |
| BMI, kg/m2 | 24,2 (22,8–25,9) | 24,8 (21,9–26,8) | 0,744 |
| Cold ischemia time, min | 455 (365–565) | 465 (400–585) | 0,329 |
| Warm ischemia time, min | 62,5 (60–70) | 67,5 (60–70) | 0,623 |
| Percentage of macrovesicular steatosis, % | 15 (0–20) | 10 (0–20) | 0,922 |
| DRI score | 1,19 (1,03–1,25) | 1,23 (1,11–1,38) | 0,186 |
Data are as median (interquartile range). BMI: body mass index, DRI: donor risk injury.